In late October, CMS announced a new “International Pricing Index” payment model to reduce the cost of prescription drugs. Premier previously put together a summary of the proposed rule that would institute a mandatory program for half of the country on how Medicare Part B drugs are acquired by providers and reimbursed.
In this Advisor Live, Soumi Saha (Sr. Director of Advocacy, Premier) and Brad Kile (President, Dumbarton Group) will review Premier’s draft comments and proposed solutions to areas of concern in the proposed IPI model.
- Soumi Saha, Sr. Director of Advocacy, Premier
- Brad Kile, President, Dumbarton Group